Application of Gold Nanorods for Plasmonic and Magnetic Imaging of Cancer Cells
- 485 Downloads
We report the use of biocompatible gold nanorods (GNRs) as multimodal (plasmonic and magnetic) probes for cancer cell labeling in vitro. These multifunctional and multimodal bioconjugates were prepared by replacing cetyltrimethylammonium bromide with a mixture of functionalized PEGylation molecules so that a variety of functionalities (e.g., magnetic resonance imaging agent gadolinium (Gd) and biorecognition molecule transferrin (Tf)) can be easily integrated using simple chemistry. It was shown that Gd incorporation did not interfere with the plasmonic properties of the GNRs and a strong T1 relaxivity was estimated (10.0 mM−1 s−1), which is more than twice that of the clinical MRI agent Gd-DTPA. The large observed T1 relaxivity was possibly due to the huge surface to volume ratio of GNR, which allowed huge amount of amine-terminated molecule to anchor on the surface, coupled with Gd (III) ions for the enhanced relaxation of water protons. Pancreatic cancer cell overexpressing the transferring receptor was served as the in vitro model, and the Tf-mediated uptake was demonstrated and confirmed by dark-field imaging and transmission electron microscopy. More importantly, cell viability (MTS) assay did not reveal any sign of toxicity in these treated cells, suggesting that PEGylated GNRs can serve as a biocompatible, multifunctional, and multimodal platform for variable bio-applications.
KeywordsGold nanorods Cancer Dark-field imaging MRI DOTA Gd
This work was supported by grants from the National Cancer Institute/National Institutes for Health (RO1-CA-119397) and the start-up grant of the International Joint Research Center for Nanophotonics and Biophotonics (IJRCNB).
- 1.Prasad PN (2003) Wiley-Interscience, New YorkGoogle Scholar
- 2.Prasad PN (2004) Wiley-Interscience, New YorkGoogle Scholar
- 18.Sullivan DC, Ferrari M (2004) Nanotechnology and tumor imaging: seizing an opportunity. In: Molecular imaging, B.C. Decker IncGoogle Scholar
- 22.Yong KT (2009) Nanotechnology 20:15102Google Scholar
- 23.Sokolov K, Follen M, Aaron J, Pavlova I, Malpica A, Lotan R, Richards-Kortum R (2003) Cancer Res 63:1999–2004Google Scholar
- 29.Kopwitthaya A, Yong K-T, Hu R, Roy I, Ding H, Vathy LA, Bergey EJ, Prasad PN (2010) Nanotechnoloy 21:315101Google Scholar
- 30.Zhu J, Yong K-T, Roy I , Hu R, Ding H, Zhao LL, Swihart MT, He GS, Cui YP, Prasad PN (2010) Nanotechnology 21:285106Google Scholar